Antiinfective Agents Affecting Cognition: A Review

References

• Morrison RL, Katz IR. Drug-related cognitive impair-ment: current progress and recurrent problems. Annu Rev Gerontol Geriatr. 1989; 9: 232–79.
   PubMedGoogle Scholar
• Moore AR, O'Keeffe ST. Drug-induced cognitive impair-ment in the elderly. Drugs Aging. 1999; 15: 15–28.
   PubMed Web of Science ®Google Scholar
• Tombaugh TN, McIntyre NJ. The mini-mental state examination: a comprehensive review. J Am Geriatr Soc. 1992; 40: 922–35.
   PubMed Web of Science ®Google Scholar
• Skinner B F. Science and Human Behavior. MacMillan, New York, 1953.
   Google Scholar
• Feldman OS, Quenzer LF. Principles of Behavioral Pharmacology. In: Fundamental of Neuropsychopharma-cology. Massachusetts, Sinauer Associates, Inc., 1984: 30.
   Google Scholar
• Bernardi RB, Barros HM. Carbamazepine enhances dis-criminative memory in a rat model of epilepsy. Epilepsia. 2004; 45: 1443–7.
   PubMed Web of Science ®Google Scholar
• Snavely SR, Hodges GR. The neurotoxicity of antibacte-rial agents. Ann Intern Med. 1984; 101: 92–104.
   PubMed Web of Science ®Google Scholar
• Bekinschtein P, Cammarota M, Igaz LM, Bevilaqua LR, Izquierdo I, Medina JH. Persistence of long-term memory stor-age requires a late protein synthesis- and BDNF- dependent phase in the hippocampus. Neuron 2007; 53: 261–77.
   PubMed Web of Science ®Google Scholar
• Morris RC, Inglis J, Ainge JA, Olverman HJ, Tulloch J, Dudai Y, Kelly PA. Memory reconsolidation: sensitivity of spa-tial memory to inhibition of protein synthesis in dorsal hip-pocampus during encoding and retrieval. Neuron 2006; 50: 479–89.
   PubMed Web of Science ®Google Scholar
• Quinton EE, Kramarcy NR. Memory impairment corre-lates closely with cycloheximide dose and degree of inhibition of protein synthesis. Brain Res 1977; 131: 184–90.
   PubMed Web of Science ®Google Scholar
• Huang T, McDonough CB, Abel T. Compartmentalized PKA signaling events are required for synaptic tagging and capture during hippocampal late-phase long-term potentiation. Eur J Cell Biol. 2006; 85: 635–42.
   PubMed Web of Science ®Google Scholar
• Downham TF, Cawley RA, Salley SO, Dal Santo G. Systemic toxic reactions to procaine penicillin G. Sex Transm Dis. 1978; 5: 4–9.
   PubMed Web of Science ®Google Scholar
• Slaker RA, Danielson B. Neurotoxicity associated with ceftazidime therapy in geriatric patients with renal dysfunction. Pharmacotherapy 1991; 4: 351–2.
   Google Scholar
• Thomas RJ, Reagan DR. Association of a Tourette-like syndrome with ofloxacin. Ann Pharmacother. 1996; 30: 138–41.
   PubMed Web of Science ®Google Scholar
• Andrejak M, Schmit JL, Tondriaux A, Hary L, Debailleux S, Moore N. Neurologic side effects of fluoro-quinolones. Therapie 1992; 47: 415–18.
   PubMed Web of Science ®Google Scholar
• Weihrauch TR, Hoffler D, Krieglstein J. The neurotoxic effect of benzylpenicillin and semisynthetic penicillins in the rabbit. Proceedings of the European Society for the study of drug toxicity. 1974; 15: 52–6.
   Google Scholar
• Raichle ME, Kutt H, Louis S, McDowell F. Neurotoxicity of intravenously administered penicillin G Arch Neurol 1971; 25: 232–9.
   PubMedGoogle Scholar
• Conway N, Beck E, Somerville J. Penicillin encephalopathy. Postgrad Med J 1968; 44: 891–7.
   PubMed Web of Science ®Google Scholar
• Schliamser SE, Cars 0, Norrby SR. Neurotoxicity of beta-lactam antibiotics: predisposing factors and pathogenesis. J Antimicrob Chemother. 1991; 27: 405–25.
   Google Scholar
• Porter J, Jick H. Drug-induced anaphylaxis, convul-sions, deafness and extrapyramidal symptoms. Lancet 1977; 1: 587–8.
   PubMed Web of Science ®Google Scholar
• Kozan R, Ayyildiz M, Yildirim M, Agar E. The effects of ethanol intake and withdrawal on penicillin-induced epilepti-form activity in rats. Brain Res Bull 2006; 71: 111–5.
   PubMed Web of Science ®Google Scholar
• Fertziger A, Rank J. Potassium accumulation in intersti-tial space during epileptiform seizures. Exper Neurol 1970; 7: 234–23.
   Google Scholar
• Olton DS. Specific deficits in active avoidance behavior following penicillin injection into hippocampus. Physiol Behav 1970; 5: 957–63.
   PubMed Web of Science ®Google Scholar
• Schmaltz LW. Deficit in active avoidance learning in rats following penicillin injection into hippocampus. Physiol Behav 1971; 6: 667–74.
   PubMed Web of Science ®Google Scholar
• Schmaltz LW, Wolf BP, Trejo WR. FR, DRL, and dis-crimination learning in rats following aspiration lesions and penicillin injection into hippocampus. Physiol Behav 1973; 11: 17–22.
   PubMed Web of Science ®Google Scholar
• Oliver DJ. Hallucinations associated with amoxycillin? A case report. Practitioner 1984; 228: 884.
   PubMedGoogle Scholar
• McAreavey D, Redding PJ. Staphylococcal septicaemia complicated by probable cloxacillin neurotoxicity and by jaun-dice induced by fusidic acid. Scott Med J 1983; 28: 179–80.
   PubMed Web of Science ®Google Scholar
• Kallay MC, Tabechian H, Riley GR, Chessin LN. Neurotoxicity due to ticarcillin in a patient with renal failure. Lancet 1979; 1: 608–9.
   PubMed Web of Science ®Google Scholar
• Antoniadis A, Muller WE, Wollen U. Benzodiazepine receptor interactions may be involved in the neurotoxicity of various penicillin derivatives. Ann Neurol 1980; 8: 71–3.
   PubMed Web of Science ®Google Scholar
• Mychajlonka M. Effects of low penicillin concentrations on cell Morphology and on peptidoglycan and protein synthe-sis in a tolerant streptococcus strain. Antimicrob Agents Chemother 1981; 19 (6): 972–79.
   PubMed Web of Science ®Google Scholar
• Pêrez-Capilla T, Baquero MR, Geimez-Geimez JM, Ionel A, Martin S, Blázquez J. SOS-independent induction of dinB transcription by beta-lactam-mediated inhibition of cell wall synthesis in Escherichia coli. J Bacteriol 2005; 187: 1515–8.
   PubMed Web of Science ®Google Scholar
• Flexner LB, Flexner JB, De La Haba G, Roberts RB. Loss of memory as related to inhibition of cerebral protein synthesis. J Neurochem 1965; 12: 535–41.
   PubMed Web of Science ®Google Scholar
• Wu MJ, Narsette TA, Hussey JL, Weinstein AB, Wen SF. Cephalothin neurotoxicity in renal failure. Ann Intern Med 1978; 89: 429.
   PubMed Web of Science ®Google Scholar
• Tollefson G. Neuropsychiatric sequelae and cephaloth-in. J Clin Psychiatr 1984; 45: 96.
   PubMed Web of Science ®Google Scholar
• Herd AM, Ross CA, Bhattacharya SK. Acute confu-sional state with postoperative intravenous cefazolin. Br Med J 1989; 299: 393–4.
   PubMedGoogle Scholar
• Geyer J, Hoffler D, Demers HG, Niemeyer R. Cephalosporin-induced encephalopathy in uremic patients. Nephron 1988; 48: 237.
   PubMed Web of Science ®Google Scholar
• Al-Zahawi MF, Sprott MS, Hendrick DJ. Hallucinations in association with ceftazidime. Br Med J 1988; 297: 858.
   PubMedGoogle Scholar
• Vincken W. Psychotic reaction to cefuroxime. Lancet 1984; 1, 965.
   PubMed Web of Science ®Google Scholar
• Kai S, Kohmura H, Ishikawa K, Kawano S, Sakai A, Kuroyanagi K, ET AL. [Reproductive and developmental toxic-ity studies on cefepime dihydrochloride administered subcuta-neously to rats during the premating, gestation and lactation periods]. Jpn J Antibiot 1992; 45: 642–60.
   PubMedGoogle Scholar
• Sugiyama 0, Watanabe S, Tanaka K, Toya M, Igarashi S, Watanabe K, ET AL. [Perinatal and postnatal study of cef-pirome sulfate in rats. J Toxicol Sci. 1990; 15: 91–107.
   Google Scholar
• Chow KM, Szeto CC, Hui AC, Wong TY, Li PK. Retrospective review of neurotoxicity induced by cefepime and ceftazidime. Pharmacotherapy 2003; 23: 369–73.
   PubMed Web of Science ®Google Scholar
• Sugimoto M, Uchida I, Mashimo T, Yamazaki S, Hatano K, Ikeda F, et al. Evidence for the involvement of GABA(A) receptor blockade in convulsions induced by cephalosporins. Neuropharmacology 2003; 45: 304–14.
   PubMed Web of Science ®Google Scholar
• McCartney CF, Hatley LH, Kessler JM. Possible tobramycin delirium. JAMA. 1982; 247:1319.
   PubMed Web of Science ®Google Scholar
• Hamilton DJ. Possible tobramycin delirium. JAMA. 1982; 248: 1971–2.
   PubMed Web of Science ®Google Scholar
• Mehta R, Champney WS. 30S ribosomal subunit assembly is a target for inhibition by aminoglycosides in Escherichia coli. Antimicrob Agents Chemother. 2002 ; 46: 1546–9.
   PubMed Web of Science ®Google Scholar
• Idzikowski C, Oswald I. Interference with human mem-ory by an antibiotic. Psychopharmacology (Berl). 1983; 79: 108–10.
   PubMed Web of Science ®Google Scholar
• Thomas M, Ashizawa T, Jankovic J. Minocycline in Huntington's disease: a pilot study. Mov Disord 2004; 19: 692–5.
   PubMed Web of Science ®Google Scholar
• Liu Z, Fan Y, Won SJ, Neumann M, Hu D, Zhou L, et al. Chronic treatment with minocycline preserves adult new neurons and reduces functional impairment after focal cerebral ischemia. Stroke 2007; 38: 146–52.
   PubMed Web of Science ®Google Scholar
• Sjögren M, Folkesson S, Blennow K, Tarkowski E. Increased intrathecal inflammatory activity in frontotemporal dementia: pathophysiological implications. J Neurol Neurosurg Psych 2004; 75: 1107–11.
   PubMed Web of Science ®Google Scholar
• Xiang Z, Haroutunian V, Ho L, Purohit D, Pasinetti GM. Microglia activation in the brain as inflammatory bio-marker of Alzheimer's disease neuropathology and clinical dementia. Dis Markers 2006; 22: 95–102.
   PubMed Web of Science ®Google Scholar
• Freeman FM, Young IC. Chloramphenicol-induced amnesia for passive avoidance training in the day-old chick. Neurobiol Learn Mem 1999; 71: 80–93.
   PubMed Web of Science ®Google Scholar
• Fride E, Ben-Or S, Allweis C. Mitochondrial protein synthesis may be involved in long-term memory formation. Pharmacol Biochem Behav. 1989; 32: 873–8.
   PubMed Web of Science ®Google Scholar
• Bertolini A, Poggioli R. Chloramphenicol administration during brain development: impairment of avoidance learning in adulthood. Science 1981; 213: 238–9.
   PubMed Web of Science ®Google Scholar
• Thompson J, O'Connor M, Mills JA, Dahlberg AE. The protein synthesis inhibitors, oxazolidinones and chloram-phenicol, cause extensive translational inaccuracy in vivo. J Mol Biol 2002; 322: 273–9.
   PubMed Web of Science ®Google Scholar
• Bharal N, Pillai KK, Vohora D. Effects of sparfloxacin on CNS functions and urinary hydroxyproline in mice. Pharmacol Res 2006; 54: 111–7.
   PubMed Web of Science ®Google Scholar
• Perepanova TS, Darenkov AF, Kotlyarova GA, Kondratyeva EM, Sinyukhin VN, Beshliev DA. Lomefloxacin in the treatment and prevention of urogenital infection]._Urol Nefrol (Mosk). 1995; 3: 31–2.
   PubMedGoogle Scholar
• Keller H. Comparison of the adverse effect profile of different substances such as penicillins, tetracyclines, sulfon-amides and quinolones. Infection. 1991; 19: S19–24.
   PubMedGoogle Scholar
• Zhang LR, Li MH, Cheng NN, Chen BY, Wang YM. Inhibition by fluoroquinolones of K(+) currents in rat dissociat-ed hippocampal neurons. Eur J Pharmacol. 2003; 462: 9–13.
   PubMed Web of Science ®Google Scholar
• Olsen PZ, Torning K. Psychological side-effects during long-term ambulatory chemotherapy with isoniazid and PAS. Acta Tuberc Scand. 1959; 37: 89.
   PubMedGoogle Scholar
• Olsen PZ, Torning K. Isoniazid and loss of memory. Scand J Res Dis. 1968; 49:1.
   PubMedGoogle Scholar
• Theodore A, Wolf M. The effect of isoniazid on perfor-mance in school. Ann Rev Respir Dis 1970; 101: 253–7.
   Google Scholar
• Weddington WW. Delirium and depression associated with amphotericin B. Psychosomatics 1982; 23: 1076–8.
   PubMed Web of Science ®Google Scholar
• Win RE, Bower JH, Richard JF. Acute toxic delirium. Neurotoxicity of intrathecal administration of amphotericin B. Arch Intern Med. 1979; 139: 706–7.
   PubMedGoogle Scholar
• Haber RW, Joseph M. Neurological manifestations after amphotericin B therapy. Br Med J 1962; 1: 230–1.
   PubMedGoogle Scholar
• Vartain CV, Shlae EM. Intravenous acyclovir and neu-rologic effects. Ann Intern Med. 1983; 99: 568.
   Web of Science ®Google Scholar
• Saral R, Burns WH, Laskin OL, Santos GW, Leitman PS. Acyclovir prophylaxis of herpes-somplex virus infections: A randomized double-blinded controlled trial in bone marrow transplant recipients. NEJM. 1981; 305: 63–7.
   PubMed Web of Science ®Google Scholar
• Wade JC, Meyers JD. Neurologic symptoms associated with parenteral acyclovir treatment with marrow transplanta-tion. Ann Intern Med 1983; 98: 921–5.
   PubMed Web of Science ®Google Scholar
• Utley TF, Ogden JA, Gibb A, McGrath N, Anderson NE. The long-term neuropsychological outcome of herpes simplex encephalitis in a series of unselected survivors. Neuropsych Neuropsychol Behav Neurol. 1997; 10: 180–9.
   PubMedGoogle Scholar
• Haefeli WE, Schoenenberger RA, Weiss P, Ritz RF Acyclovir-induced neurotoxicity: concentration-side effect rela-tionship in acyclovir overdose. Am J Med. 1993; 94: 212–5.
   PubMed Web of Science ®Google Scholar
• McGuirt PV, Furman PA. Acyclovir inhibition of viral DNA chain elongation in herpes simplex virus-infected cells. Am J Med. 1982; 73: 67–71.
   PubMed Web of Science ®Google Scholar
• Haas J, Meyding-Lamade U, Fath A, Stingele K, Storch-Hagenlocher B, Wildemann B. Acyclovir treatment of experimentally induced herpes simplex virus encephalitis: monitoring the changes in immunologic NO synthase expres-sion and viral load within brain tissue of SJL mice. Neurosci Lett. 1999; 264: 129–32.
   PubMed Web of Science ®Google Scholar
• Yildiz Akar F, Ulak G, Tanyeri P, Erden F, Utkan T, Gacar N. 7-Nitroindazole, a neuronal nitric oxide synthase inhibitor, impairs passive-avoidance and elevated plus-maze memory performance in rats. Pharmacol Biochem Behav 2007; [Epub ahead of print].
   Google Scholar
• Crone CC, Gabriel GM, Wise TN. Managing the neu-ropsychiatric side effects of interferon-based therapy for hepatitis C. Cleve Clin J Med. 2004; 71: S27–32.
   PubMedGoogle Scholar
• Valentine AD, Meyers CA. Neurobehavioral effects of interferon therapy. Curr Psych Rep. 2005; 7: 391–5.
   PubMedGoogle Scholar
• Hilsabeck RC, Hassanein TI, Ziegler EA, Carlson MD, Perry W. Effect of interferon-alpha on cognitive functioning in patients with chronic hepatitis C. J Int Neuropsychol Soc. 2005; 11: 16–22.
   PubMed Web of Science ®Google Scholar
• Kraus MR, Schafer A, Wissmann S, Reimer P, Scheurlen M. Neurocognitive changes in patients with hepati-tis C receiving interferon alfa-2b and ribavirin. Clin Pharmacol Ther. 2005; 77: 90–100.
   PubMed Web of Science ®Google Scholar
• Amodio P, De Toni EN, Cavalletto L, Mapelli D, Bernardinello E, Del Piccolo F, et al. Mood, cognition and EEG changes during interferon alpha (alpha-IFN) treatment for chronic hepatitis C. J Affect Disord. 2005; 84: 93–8.
   PubMed Web of Science ®Google Scholar
• Cabrera-Gomez JA, Echazabal-Santana N, Porrero-Martin P, Valenzuela-Silva C, Rodriguez CA, Fuentes-Suarez I, et al. [Interferon-alpha2b recombinant improved the cognitive dysfunction in patients with relapsing remitting multiple sclero-sis]. Rev Neurol 2003; 37: 214–20.
   PubMed Web of Science ®Google Scholar
• Zivadinov R, Zorzon M, Tommasi MA, Nasuelli D, Bernardi M, Monti-Bragadin L, et al. A longitudinal study of quality of life and side effects in patients with multiple scle-rosis treated with interferon beta-la. J Neurol Sci. 2003; 216: 113–8.
   PubMed Web of Science ®Google Scholar
• Scheibel RS, Valentine AD, O'Brien S, Meyers CA. Cognitive dysfunction and depression during treatment with interferon-alpha and chemotherapy. J Neuropsych Clin Neurosci. 2004; 16: 185–91.
   PubMed Web of Science ®Google Scholar
• Gochee PA, Powell EE, Purdie DM, Pandeya N, Kelemen L, Shorthouse C, et al. Association between apolipoprotein E epsilon4 and neuropsychiatric symptoms during interferon alpha treatment for chronic hepatitis C. Psychosomatics. 2004; 45: 49–57.
   PubMed Web of Science ®Google Scholar
• Giancola ML, Lorenzini P, Balestra P, Larussa D, Baldini F, Corpolongo A, et al. Neuroactive antiretroviral drugs do not influence neurocognitive performance in less advanced HIV-infected patients responding to highly active antiretroviral therapy. J Acquir Immune Defic Syndr. 2006; 41: 332–7.
   PubMed Web of Science ®Google Scholar
• Beers SR, Skold A, Dixon CE, Adelson PD. Neurobehavioral effects of amantadine after pediatric traumat-ic brain injury: a preliminary report. J Head Trauma Rehabil. 2005; 20: 450–63.
   PubMed Web of Science ®Google Scholar
• Storozhuk VM, Zinyuk LE. Specific features of sensori-motor cerebral cortex activity modulation by dopamine releas-er amantadine. Exp Brain Res. 2007; [Epub ahead of print].
   Google Scholar
• Honey GD, Bullmore ET, Soni W, Varatheesan M, Williams SC, Sharma T. Differences in frontal cortical activa- tion by a working memory task after substitution of risperi-done for typical antipsychotic drugs in patients with schizo-phrenia. Proc Natl Acad Sci U S A. 1999; 96: 13432–7.
   PubMed Web of Science ®Google Scholar
• Calamandrei G, Venerosi A, Branchi I, Valanzano A, Puopolo M, Alleva E. Neurobehavioral effects of prenatal lamivudine (3TC) exposure in preweaning mice. Neurotoxicol Teratol. 1999; 21: 365–73.
   PubMed Web of Science ®Google Scholar
• Anokhin KV, Belotserkovskaia NA, Kraevskii AA. [Disordered long-term memory in mice as affected by azi-dothymidine]. Bull Eksp Biol Med. 1988; 106: 144–5.
   Google Scholar
• Levin ED, Brunssen S, Wolfe GW, Harry GJ. Neurobehavioral assessment of mice after developmental AZT exposure. Neurotoxicol Teratol. 2004; 26: 65–71.
   PubMed Web of Science ®Google Scholar
• Good MI, Shader RI. Behavioral toxicity and equivocal suicide associated with chloroquine and its derivatives. Am J Psych. 1977; 134: 798–801.
   PubMed Web of Science ®Google Scholar
• Cras P, Martin J. Transient global amnesia following ingestion of chloroquine. J Neurol Neurosurg Psych 1990; 53:926.
   PubMed Web of Science ®Google Scholar
• Kaeser HE. Transient global amnesia due to clioquinol. Avta Neurol Scand 1984; 70: 175–9.
   Web of Science ®Google Scholar
• Yoshimura S, Imai K, Saitoh Y, Yamaguchi H, Ohtaki S. The same chemicals induce different neurotoxicity when administered in high doses for short term or low doses for long term to rats and dogs. Mol Chem Neuropathol. 1992; 16: 59–84.
   Google Scholar
• Ritchie CW, Bush Al, Mackinnon A, Macfarlane S, Mastwyk M, MacGregor L, et al. Metal-protein attenuation with iodochlorhydroxyquin (clioquinol) targeting Abeta amyloid deposition and toxicity in Alzheimer disease: a pilot phase 2 clinical trial. Arch Neurol. 2003; 60: 1685-91.
   Google Scholar
• Doraiswamy PM, Finefrock AE. Metals in our minds: therapeutic implications for neurodegenerative disorders. Lancet Neurol 2004; 3: 431–4
   PubMed Web of Science ®Google Scholar
• Schentag JJ, Ziemniak JA, Greco JM, Rainstein M, Buckley RJ. Mental confusion in a patient treated with metronidazole-a concentration-related effect? Pharmaco-therapy. 1982; 2: 384–7.
   Google Scholar
• Lieben CK, Blokland A, Sik A, Sung E, van Nieuwenhuizen P, Schreiber R. The selective 5-HT6 receptor antagonist Ro4368554 restores memory performance in cholinergic and serotonergic models of memory deficiency in the rat. Neuropsychopharmacology 2005; 30: 2169-79.
   Google Scholar
• van der Staay FJ, Bouger PC. Effects of the cholinesterase inhibitors donepezil and metrifonate on scopo-lamine-induced impairments in the spatial cone field orienta-tion task in rats. Behav Brain Res 2005; 156: 1–10.
   PubMed Web of Science ®Google Scholar
• López-Arrieta JM, Schneider L. Metrifonate for Alzheimer's disease. Cochrane Database Syst Rev 2006; (2): CD003155.Merlo E, Freudenthal R, Romano A. The IkB Kinase inhibitor sulfasalazine impairs long-term memory in the Crab Chasmagnathus. Neuroscience 2002; 112: 161–72.
   Google Scholar
• Wahl C, Liptay S, Wirth T, Addler G, Schmid R. Sulfasalazine: a potent and specific inhibitor of nuclear factor nuclear factor kappa. B J Clin Invest. 1998; 101: 1163–74.
   PubMed Web of Science ®Google Scholar
• Delorenzi A, Maldonado H. Memory enhancement by the angiotensinergic system in the crab Chasmagnathus is mediated by endogenous angiotensin II. Neurosci Lett 1999; 266: 1–4.
   PubMed Web of Science ®Google Scholar
• Nicholls PJ. Neurotoxicity of penicillin. J Antimicrob Chemother 1980; 6: 161–5.
   PubMed Web of Science ®Google Scholar